ArticleCell death & disease2025

Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers.

Baris Sergi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.